Stock Analiz

Organon & Co. (OGN) financials: revenue, earnings and cash flow

Fiscal 2019–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Organon &’s revenue went from $7.8B in fiscal 2019 to $6.2B in fiscal 2025, a decline of about 3.7% a year.

Net income in fiscal 2025 was $187M, a net margin of 3.0%; the best year in this period was 2019 with $3.2B.

Over the twelve months to September 30, 2026, revenue was $6.1B and net income $213M.

Free cash flow was $538M in fiscal 2025 and positive in 7 of the 7 years shown.

The diluted share count rose 3% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2019: $7.8B20192020: $6.5B20202021: $6.3B20212022: $6.2B20222023: $6.3B20232024: $6.4B20242025: $6.2B2025$6.2B
Net income
2019: $3.2B20192020: $2.2B20202021: $1.4B20212022: $917M20222023: $1.0B20232024: $864M20242025: $187M2025$187M
Free cash flow
2019: $2.9B20192020: $2.0B20202021: $2.0B20212022: $662M20222023: $548M20232024: $764M20242025: $538M2025$538M
EPS (diluted)
2019: $12.6920192020: $8.5220202021: $5.3120212022: $3.5920222023: $3.9920232024: $3.3320242025: $0.722025$0.72

Income statement

Fiscal yearTTM2025202420232022202120202019
Revenue$6.1B$6.2B$6.4B$6.3B$6.2B$6.3B$6.5B$7.8B
Gross profit$3.2B$3.3B$3.7B$3.7B$3.9B$3.9B$4.4B$5.5B
Operating income$949M$929M$1.3B$1.2B$1.5B$1.8B$2.8B$3.7B
Net income$213M$187M$864M$1.0B$917M$1.4B$2.2B$3.2B
EPS (diluted)$0.77$0.72$3.33$3.99$3.59$5.31$8.52$12.69
R&D$357M$366M$469M$528M$471M$443M$210M$220M
Revenue growth—−2.9%+2.2%+1.4%−2.1%−3.5%−16.0%—

Cash flow

Fiscal yearTTM2025202420232022202120202019
Operating cash flow$843M$700M$939M$799M$858M$2.2B$2.3B$3.0B
Capital spending-$168M-$162M-$175M-$251M-$196M-$192M-$255M-$92M
Free cash flow$675M$538M$764M$548M$662M$2.0B$2.0B$2.9B
Dividends paid$20M$88M$297M$294M$290M$145M$0$0
Buybacks————————
Stock-based pay$72M$77M$105M$101M$75M$59M$40M$41M

Balance sheet

Fiscal yearTTM2025202420232022202120202019
Cash—$574M$675M$693M$706M$737M$12M—
Debt—$8.8B$9.0B$8.9B$9.1B$9.4B$31M—
Equity—$752M$472M-$70M-$892M-$1.5B$5.5B$7.0B
Total assets—$12.9B$13.1B$12.1B$11.0B$10.7B$10.1B—
Shares (diluted)272M261M259M256M255M254M254M254M

Margins and returns

Fiscal yearTTM2025202420232022202120202019
Gross margin53.1%53.3%58.0%59.8%62.8%62.2%67.6%70.8%
Operating margin15.6%14.9%20.7%19.2%25.0%28.3%42.1%47.5%
Net margin3.5%3.0%13.5%16.3%14.8%21.4%33.1%41.4%
FCF margin11.1%8.7%11.9%8.8%10.7%31.2%31.1%37.6%
ROIC—7.7%11.0%10.7%15.3%20.1%40.9%47.0%
ROE—24.9%183.1%-1461.4%-102.8%-89.6%39.4%45.7%

Frequently asked questions

What is Organon &’s annual revenue?

$6.2B in fiscal 2025 and $6.1B over the twelve months to September 30, 2026.

How much profit does Organon & make?

Net income was $187M in fiscal 2025 (net margin 3.0%).

Is Organon &’s revenue growing?

No: revenue fell 2.9% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.